Morningstar Investment Services LLC boosted its holdings in shares of Shire PLC (NASDAQ:SHPG) by 53.0% during the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 25,882 shares of the biopharmaceutical company’s stock after purchasing an additional 8,969 shares during the quarter. Morningstar Investment Services LLC’s holdings in Shire PLC were worth $3,964,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds have also modified their holdings of SHPG. Sphera Funds Management LTD. increased its stake in Shire PLC by 26.3% in the 3rd quarter. Sphera Funds Management LTD. now owns 86,500 shares of the biopharmaceutical company’s stock worth $13,247,000 after acquiring an additional 18,000 shares during the last quarter. Van ECK Associates Corp increased its stake in Shire PLC by 222.6% in the 3rd quarter. Van ECK Associates Corp now owns 232,859 shares of the biopharmaceutical company’s stock worth $35,660,000 after acquiring an additional 160,677 shares during the last quarter. Davidson Investment Advisors increased its stake in Shire PLC by 19.4% in the 3rd quarter. Davidson Investment Advisors now owns 44,494 shares of the biopharmaceutical company’s stock worth $6,813,000 after acquiring an additional 7,220 shares during the last quarter. D.A. Davidson & CO. increased its stake in Shire PLC by 16.5% in the 3rd quarter. D.A. Davidson & CO. now owns 16,471 shares of the biopharmaceutical company’s stock worth $2,522,000 after acquiring an additional 2,330 shares during the last quarter. Finally, First Interstate Bank increased its stake in Shire PLC by 4,400.0% in the 3rd quarter. First Interstate Bank now owns 1,620 shares of the biopharmaceutical company’s stock worth $248,000 after acquiring an additional 1,584 shares during the last quarter. 18.64% of the stock is currently owned by institutional investors.

COPYRIGHT VIOLATION WARNING: “Shire PLC (SHPG) Position Increased by Morningstar Investment Services LLC” was originally published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another website, it was copied illegally and republished in violation of international copyright & trademark legislation. The original version of this piece of content can be accessed at https://www.watchlistnews.com/shire-plc-shpg-position-increased-by-morningstar-investment-services-llc/1723449.html.

Shire PLC (NASDAQ:SHPG) opened at $149.78 on Friday. The company has a market capitalization of $44,997.96, a P/E ratio of 10.30, a PEG ratio of 0.83 and a beta of 1.60. The company has a quick ratio of 0.52, a current ratio of 0.98 and a debt-to-equity ratio of 0.55. Shire PLC has a 1-year low of $137.17 and a 1-year high of $192.15.

Shire PLC (NASDAQ:SHPG) last announced its earnings results on Friday, October 27th. The biopharmaceutical company reported $3.81 EPS for the quarter, topping the Zacks’ consensus estimate of $3.64 by $0.17. The firm had revenue of $3.70 billion during the quarter. Shire PLC had a return on equity of 14.41% and a net margin of 10.95%. Shire PLC’s revenue for the quarter was up 7.1% compared to the same quarter last year. During the same quarter last year, the firm posted $3.17 EPS. research analysts forecast that Shire PLC will post 15 earnings per share for the current year.

A number of analysts have issued reports on the company. Royal Bank Of Canada reaffirmed a “buy” rating on shares of Shire PLC in a research note on Thursday, November 16th. Cantor Fitzgerald set a $222.00 price objective on Shire PLC and gave the stock a “buy” rating in a research note on Thursday, November 16th. Liberum Capital raised Shire PLC from a “hold” rating to a “buy” rating in a research note on Tuesday, November 14th. FBR & Co reaffirmed a “buy” rating and issued a $201.00 price objective on shares of Shire PLC in a research note on Monday, October 30th. Finally, Cowen Inc set a $225.00 price objective on Shire PLC and gave the stock a “buy” rating in a research note on Sunday, October 29th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and eleven have assigned a buy rating to the company’s stock. Shire PLC currently has a consensus rating of “Buy” and a consensus price target of $212.18.

About Shire PLC

Shire plc is a biotech company focused on serving people with rare diseases and other specialized conditions. The Company’s segment is engaged in research, development, licensing, manufacturing, marketing, distribution and sale of specialist medicines. It focuses its development resources on projects in various therapeutic areas (TAs), including Neuroscience, Ophthalmology, Hematology, Oncology, Immunology, Gastrointestinal (GI)/Metabolic/Endocrinology Diseases.

Want to see what other hedge funds are holding SHPG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Shire PLC (NASDAQ:SHPG).

Institutional Ownership by Quarter for Shire PLC (NASDAQ:SHPG)

Receive News & Ratings for Shire PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Shire PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.